Health
Identifying Platinum Chemotherapy Resistance in Patients With Ovarian Cancer – Technology Networks
Researchers have discovered a way to predict which patients with ovarian cancer are resistant to platinum chemotherapy.
Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards. To improve their survival, there is a need to first identify which patients may be platinum-resistant, so that newer treatments may be administered early.
Now, researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National…
-
General19 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News18 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News18 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News19 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland